)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Mauna Kea Technologies
Mauna Kea Technologies (ALMKT) investor relations material
Mauna Kea Technologies Q3 2026 TU earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2026 TU earnings summary20 Oct, 2026
Executive summary
9M 2026 sales reached €4,409K, up 21% reported and 24% at constant exchange rates; excluding China, the highest 9M sales in six years.
Recurring revenue rose 17% at constant exchange rates to €2.9m; 10 systems sold versus six in 9M 2025.
Q3 sales fell 10% reported and 11% at constant exchange rates amid temporary U.S. staffing gaps and system shipments scheduled for Q4.
Financial highlights
9M product sales totaled €4,409K versus €3,645K in 9M 2025, up 21% reported and 24% at constant exchange rates.
Q3 product sales were €1,206K versus €1,343K, down 10% reported and 11% at constant exchange rates.
Recurring sales from probes, pay-per-use and services rose 17% at constant exchange rates to €2.9m, representing 67% of 9M sales.
U.S. sales were €2,938K, up 1%; EMEA and Rest of World sales were €1,471K, up 128%.
Outlook and guidance
Q4 is historically the strongest quarter; Q4 2025 sales were €1,944K, and the systems pipeline is mostly weighted to Q4.
Q4 opportunities include pancreatic-lesion systems, U.S. systems nearing maintenance end, and international pipeline, including Turkey and the Middle East.
All four U.S. territories were staffed by October, each with a Territory Manager and Clinical Associate.
TaeWoong’s dedicated team is targeting more than 200 potential accounts; additional partnerships are under consideration to expand Cellvizio’s reach.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Mauna Kea Technologies
- H1 sales grew 44% at CER as CellTolerance and pancreatic adoption fueled expansion.ALMKT
Corporate presentation - CellTolerance-led revenue rose 37%; forecasts support operations through end-2027.ALMKTH1 2026
- Sales up 44% in H1 2026, driven by U.S. probe and CellTolerance growth, targeting profitability.ALMKTQ2 2026 TU
- Rapid clinical adoption and high-margin growth position the platform for global expansion and profitability.ALMKTCorporate presentation
- Cellvizio's clinical innovation and commercial momentum fuel accelerated growth and profitability.ALMKTCorporate presentation
- Debt dropped 69%, net profit hit €10.8M, and sales momentum accelerated into 2026.ALMKTH2 2025
- Sales rose 68% at CER, driven by U.S. and international demand and major debt reduction.ALMKTQ1 2026 TU
- Revenue fell 5% as US sales rose and safeguard plan targets debt reduction, supporting growth.ALMKTH1 2025
- H1 2024 revenue fell 43%, net loss was €4.7M, and Q3 sales rose 24% year-over-year.ALMKTH1 2024 & Q3 2024 TU
Mauna Kea Technologies
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage